2020 Nelson's Pediatric Antimicrobial Therapy
Summary
The feel-good place to buy books
2020 Nelson's Pediatric Antimicrobial Therapy by John S Bradley
The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens. New in the 26th edition:- First pediatric approval of beta-lactam/beta-lactamase inhibitor for CRE (carbapenem-resistant enteric bacilli), ceftazidime-avibactam
- Replacement antibiotics for cefotaxime (lack of availability in the US), including ceftriaxone and cefepime (for neonates)
- Situations in which ceftaroline is preferred over vancomycin by the Editors for MRSA infections
- Updates on management of influenza, including baloxavir (now approved for children >12 years)
- New approaches to treatment of mucomycosis
- New recommendations for malaria
- More than 150 new references>
2020 Nelson's Pediatric Antimicrobial Therapy has been selected as one of Doody’s Core Titles®
| SKU | Unavailable |
| ISBN 13 | 9781610023528 |
| ISBN 10 | 1610023528 |
| Title | 2020 Nelson's Pediatric Antimicrobial Therapy |
| Author | John S Bradley |
| Condition | Unavailable |
| Binding Type | Paperback |
| Publisher | American Academy of Pediatrics |
| Year published | 2020-01-30 |
| Number of pages | 320 |
| Cover note | Book picture is for illustrative purposes only, actual binding, cover or edition may vary. |
| Note | Unavailable |